Pharmacists are medication experts embedded in the healthcare system who play a direct and often underappreciated role in managing dementia symptoms. While doctors prescribe the medications, pharmacists are the clinicians who understand how those drugs interact with each other, what side effects might emerge, and whether a patient’s current regimen is actually helping or harming them. For a person with dementia, a pharmacist’s review can mean the difference between a medication regimen that manages confusion, agitation, and sleep disturbance versus one that worsens all three.
A 72-year-old with early Alzheimer’s disease might see their confusion improve dramatically when a pharmacist identifies that an over-the-counter sleep aid prescribed by their internist was conflicting with their dementia medication and actually accelerating cognitive decline. Pharmacists contribute to dementia symptom control through several concrete mechanisms: they catch dangerous drug interactions before they cause a crisis, they identify and recommend deprescribing (stopping) medications that no longer serve the patient, they monitor whether prescribed medications are actually reducing behavioral symptoms like wandering or aggression, and they counsel caregivers on how to administer medications safely when a patient can no longer manage a pill organizer. They also flag when a symptom that looks like worsening dementia is actually a medication side effect—a distinction that can lead to a simple medication adjustment rather than months of diagnostic testing.
Table of Contents
- What Medication Problems Do Pharmacists Identify in Dementia Care?
- Deprescribing in Dementia: Why Taking Medicines Away Helps
- Behavioral Symptom Management Through Pharmacist Expertise
- Pharmacist Communication with Caregivers and Care Teams
- Safety Risks and Drug-Related Problems in Dementia
- Monitoring Cognition and Medication Efficacy Over Time
- Over-the-Counter Medications and Supplements in Dementia Care
- Frequently Asked Questions
What Medication Problems Do Pharmacists Identify in Dementia Care?
Pharmacists function as a safety checkpoint in dementia care because they have access to a patient’s complete medication list and the expertise to spot problems that individual prescribers might miss. A cardiologist prescribes a blood pressure medication, a urologist prescribes something for incontinence, a primary care doctor prescribes an antidepressant, and a patient’s family adds an over-the-counter antihistamine for allergies—and suddenly the patient has four drugs that together slow cognitive processing, increase fall risk, and cause dry mouth severe enough to trigger aspiration risk. Pharmacists are trained to see this pattern. They review the entire list and can identify which medications are contributing to which symptoms. A specific example: an 80-year-old with vascular dementia came to a pharmacist with worsening memory loss and new episodes of confusion.
The pharmacist discovered that the patient’s primary care doctor had recently added a statin at a higher dose, and this particular statin is known to cross the blood-brain barrier and can cause cognitive impairment in older adults. The patient was switched to a different statin that doesn’t cross into the brain, and within three weeks, the patient’s cognition improved noticeably. The worsening wasn’t disease progression—it was a medication side effect that a careful pharmacist review caught. Pharmacists also identify what’s called “drug-disease interactions”—situations where a medication appropriate for one condition is actively harmful in dementia. Anticholinergic drugs (medications that block acetylcholine, a key neurotransmitter) are used for many conditions—overactive bladder, chronic pain, nausea—but in dementia, anticholinergics accelerate cognitive decline and increase delirium risk. A pharmacist will flag every anticholinergic on a dementia patient’s list and work with prescribers to find alternatives.
Deprescribing in Dementia: Why Taking Medicines Away Helps
One of the most important contributions pharmacists make to dementia care is recommending the *removal* of medications—a practice called deprescribing. People with dementia often accumulate medications over years for conditions that are no longer relevant, or medications that made sense when they were cognitively intact but now cause more harm than benefit. A cholesterol medication prescribed to prevent a heart attack decades in the future makes no sense when someone is in moderate dementia with a life expectancy of 5-7 years. A blood pressure medication that causes dizziness and falls is dangerous when someone can no longer catch themselves. Pharmacists conduct a systematic review of each medication and ask: Is this still helping this person? Is it causing side effects? Is it consistent with this person’s current goals of care? The limitation of deprescribing is that it requires buy-in from multiple providers. A pharmacist might recommend stopping a blood pressure medication to reduce fall risk, but if the patient’s cardiologist prescribed it for a specific reason, that cardiologist has to agree to the change.
Sometimes there’s resistance, or miscommunication between pharmacist and physician, and the medication doesn’t get stopped. This is why pharmacists increasingly work in integrated teams where they have direct prescribing authority or collaborative agreements with physicians. A warning: deprescribing must be done carefully with gradual tapering, not abrupt cessation. Stopping some medications suddenly—beta-blockers, benzodiazepines, antidepressants—can cause rebound effects. A 75-year-old with dementia was abruptly taken off an antidepressant by a well-meaning family member trying to “reduce medications,” and the patient experienced severe anxiety and sleep disturbance that lasted weeks. A pharmacist’s involvement would have included a taper schedule and patient monitoring.
Behavioral Symptom Management Through Pharmacist Expertise
Dementia often brings behavioral changes—agitation, aggression, wandering, sleep disruption, paranoia—that are among the most difficult symptoms for families and caregivers to manage. Medications can help reduce these behaviors, but they must be chosen carefully and monitored closely. Pharmacists are the experts who help optimize these medication choices. When a doctor prescribes an antipsychotic to reduce agitation in a dementia patient, the pharmacist reviews whether that particular antipsychotic is appropriate for that particular person, what the realistic timeline is for seeing improvement, what side effects to watch for, and whether the lowest possible dose is being used. The specific challenge with behavioral symptoms is that they have multiple possible causes—pain, infection (a urinary tract infection can cause acute behavioral changes), medication side effects, environmental triggers, or the dementia itself—and a pharmacist’s job includes helping the care team distinguish between these.
A 78-year-old with Lewy body dementia became increasingly aggressive over several weeks. The family wanted medication to control the aggression. The pharmacist discovered the patient had developed a severe fungal infection under a feeding tube, which was causing the behavioral change. The infection was treated, the aggressive behavior resolved, and no psychiatric medication was needed. This kind of systematic troubleshooting is where pharmacists add tremendous value.
Pharmacist Communication with Caregivers and Care Teams
Dementia care is inherently collaborative—it involves the patient (who may have limited ability to understand medications), family caregivers, physicians, nurses, social workers, and increasingly, pharmacists. Pharmacists serve as educators and translators. They explain to families why a medication was chosen, what to expect, what side effects might appear and when to call a doctor, and how to give the medication safely if the patient becomes unable to swallow pills or take medications independently. This communication role is practical and high-value; studies show that caregiver confusion about medications is one of the top predictors of medication errors and preventable hospitalizations. A concrete example: a family brought their mother home from the hospital after a stroke complicated by dementia. She was discharged on eight medications, several new. The pharmacist sat down with the family for 30 minutes, went through each medication one by one, explained what it does, when to give it, what side effects to watch for, and when to hold the medication and call the doctor.
The family had been terrified of making a mistake. The pharmacist also identified a potentially dangerous interaction between two of the hospital’s discharge medications and recommended a change. Without this pharmacist intervention, this family would have struggled for weeks, and the patient would likely have had medication errors or confusion about administration. The tradeoff is time and access. Pharmacist consultation takes time, and not all patients have access to clinical pharmacists, especially in rural areas or in care settings with limited resources. Some insurance plans don’t reimburse for pharmacist consultation. This means disparities exist in who benefits from this level of pharmaceutical care.
Safety Risks and Drug-Related Problems in Dementia
Dementia patients are at very high risk for medication-related problems, and pharmacists are trained to anticipate these. The issues include: reduced ability to report side effects (a patient with advanced dementia can’t tell you their new medication is causing headaches), increased sensitivity to medications due to age-related changes in metabolism and kidney function, higher risk of falls from medications, increased risk of medication non-adherence because the patient forgets to take them or refuses them, and higher risk of serious interactions because these patients often have multiple chronic conditions. A warning: certain medication classes are considered high-risk in dementia specifically. Benzodiazepines (anti-anxiety medications like lorazepam) increase delirium, falls, and fractures in dementia patients and should be avoided or used only short-term at the lowest dose. Anticholinergics, as mentioned earlier, accelerate cognitive decline.
Antipsychotics carry a black-box warning for mortality risk in elderly dementia patients and should be used only when other interventions have failed. Nonsteroidal anti-inflammatory drugs (NSAIDs) increase gastrointestinal bleeding and cardiovascular risk in older adults. Pharmacists specifically watch for these drugs and recommend alternatives or close monitoring. A limitation of pharmacist involvement is that even when a pharmacist identifies a high-risk medication, the prescriber may have already determined it’s necessary for symptom control, and deprescribing isn’t an option. In these cases, the pharmacist’s role shifts to close monitoring—making sure the patient is on the lowest effective dose, that side effects are being tracked, and that the medication is actually working.
Monitoring Cognition and Medication Efficacy Over Time
As dementia progresses, what works medication-wise changes. A medication that controlled behavioral symptoms in mild dementia may cause oversedation in moderate dementia. A dosing schedule that the patient could manage independently early on becomes impossible when memory declines further. Pharmacists contribute to ongoing monitoring and adjustment.
They work with the care team to periodically reassess whether medications are still appropriate, whether doses need adjustment, whether new symptoms have emerged that need medication changes, and whether the patient’s goals of care have shifted. A specific situation: an 82-year-old on multiple medications for hypertension and heart disease developed advanced dementia and a shortened life expectancy of months to a year. The pharmacist worked with the family and palliative care team to deprescribe the blood pressure medications and heart medications that were aimed at long-term disease prevention. Instead, the focus shifted to comfort medications—something for pain, something for shortness of breath, medication to reduce excessive secretions. The pharmacist managed this transition and monitored how the patient responded to comfort-focused medications rather than life-extending ones.
Over-the-Counter Medications and Supplements in Dementia Care
A critical gap in dementia medication safety is over-the-counter (OTC) drugs and supplements. Families often don’t mention them to doctors—they’re not “real” medications, so they seem harmless—but pharmacists know better. OTC antihistamines, cold medicines, sleep aids, and pain relievers often contain anticholinergic ingredients that accelerate cognitive decline. Herbal supplements like St. John’s Wort interact with many dementia medications.
Melatonin, which families use for sleep, can cause confusion and falls in dementia patients. Ginkgo biloba, marketed for memory, actually increases bleeding risk when combined with blood thinners. A 76-year-old with mild cognitive impairment and early dementia was taking prescribed donepezil, a medication meant to slow cognitive decline, but also taking an OTC sleep aid containing diphenhydramine (an anticholinergic) every night. The anticholinergic in the sleep aid was directly counteracting the effect of the donepezil and likely accelerating dementia progression. A pharmacist review caught this conflict and recommended a non-anticholinergic alternative for sleep, after which the patient’s cognition stabilized. This situation illustrates why pharmacists ask specifically about OTC and supplement use—patients and families often don’t volunteer this information because they don’t think it’s relevant.
Frequently Asked Questions
When should someone with dementia see a pharmacist?
As soon as possible after diagnosis, and then periodically—at minimum when medications change, but ideally annually. Early pharmacist review can prevent many problems from developing.
Can a pharmacist change or stop my mother’s medications?
This depends on the setting and regulations. In most cases, pharmacists recommend changes to physicians, who must approve them. In some integrated care settings or certain states, pharmacists have collaborative prescribing authority. Always check with your healthcare team about the pharmacist’s specific role.
Is it dangerous to stop medications my relative has been on for years?
Stopping medications requires careful planning and gradual tapering in many cases. This is exactly why pharmacist involvement in deprescribing is important—they have the expertise to stop medications safely. Abrupt cessation of some drugs can be harmful.
What’s the difference between a pharmacist and a pharmacy technician?
Pharmacists have a doctorate-level degree and clinical training; they counsel patients, review medications for safety and interactions, and in some settings, prescribe. Pharmacy technicians work under pharmacist supervision and handle tasks like filling prescriptions and answering routine questions.
How can I access a clinical pharmacist if my doctor’s office doesn’t have one?
Many hospitals, geriatric clinics, memory care centers, and specialized dementia clinics employ clinical pharmacists. Some insurance plans cover pharmacist consultation. Your doctor can refer you, or ask your insurance plan whether pharmacist consultation is covered.
Should I stop giving my relative supplements to avoid interactions?
Don’t stop anything without consulting the healthcare team. Instead, tell your pharmacist and doctor about every supplement and OTC product your relative is taking so they can assess risks and benefits. Some supplements may need to stop; others may be fine with monitoring.
